University of California San Francisco

Give to UCSF
Advanced
2970 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics
Displaying 2701 - 2730 of 2970
  • Rethinking Prostate Cancer with Matthew Cooperberg, MD, MPH

    <p>In the era of prostate cancer screening, mortality rates have fallen 40 percent. The price of that has been over-diagnosis and over-treatment, something the current health care system cannot sustain. One of the major goals of Cooperberg’s research is to develop better risk assessment tools and instruments that can give the patient and doctor more confidence that the patient’s cancer will not progress.</p>

    Placeholder image
  • Mining the Human Body with Michael Fischbach, PhD

    <p>Having developed an algorithm that discovered a large quantity of drug-producing bacteria in and on humans, Fischbach has turned his lab’s attention to studying their populations and interactions with each other. This, he posits, can greatly influence a person’s overall health and disease.</p>

    Placeholder image
  • Smarter Drug Delivery with Tejal Desai, PhD

    <p>Swallowing pills means medication must face the challenge of surviving the harsh environment of the digestive tract. As a result, people must take larger doses than they need. Using micro and nano-fabrication techniques developed by the computer chip industry, Desai’s lab is creating tiny devices that take multiple drugs directly to where they are needed, using less medication, minimizing side effects and making the process safer for the patient.&nbsp;</p>

    Placeholder image
  • Treating Disease Before Birth with Tippi MacKenzie, MD

    Stem cell transplantation may hold the promise to treating many diseases before birth such as sickle cell anemia and muscular dystrophy. But first, researchers need to overcome many barriers, including rejection of stem cell transplants by the fetus. MacKenzie’s lab recently discovered that mothers’ T cells are responsible for rejecting the grafts and that this rejection may be avoided by using stem cells from the mother.

    Placeholder image
  • Learning Lessons from an HIV Cure

    <p>For doctors confronting the AIDS epidemic, past ambitions always boiled down to two main goals: prevention, or finding ways to protect people not yet exposed to HIV, through vaccines, safe sex education or other means; and treatment, or discovering effective drugs and providing them to people with HIV/AIDS, helping them live longer.</p>

    Placeholder image
  • SFGH Grand Rounds Explores Disease That First Defined AIDS

    <p>Doctors and other health care professionals packed into San Francisco General Hospital’s Carr Auditorium for the June 7 medical grand rounds, commemorating the 30th anniversary of the first AIDS report to the US Centers of Disease Control (CDC) and Prevention.</p>

    Placeholder image
  • UCSF Marks Three Decades of AIDS

    <p>As one of the preeminent biomedical education and health sciences research institutions in the world, UCSF emerged early as a pioneer in the fight against AIDS. Today, three decades later, UCSF is working on multiple fronts to prevent, treat and stop the spread of the disease that has killed 33 million people worldwide.</p>

    Placeholder image
  • UCSF Joins Caltech in Creative Problem Solving to Advance Health Care

    <p>Experts at UCSF and Caltech are pushing the boundaries of creative problem solving to address important clinical problems with the hope that the talent pool at both institutions, combined with an entrepreneurial spirit, will advance health care innovation.</p>

    Placeholder image
  • UCSF Team Discovers Key to Fighting Drug-Resistant Leukemia

    Targeting a protein that leukemia cells use to stay alive may be the key to fighting drug-resistant leukemia, a discovery that may make cancer drugs more powerful and help doctors formulate drug cocktails to cure more children of leukemia, a team led by UCSF researchers reports.

    Placeholder image
  • UCSF Scientists Play Key Role in Success of Yervoy, a New Cancer Drug

    <p>Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma –&nbsp;and that is being used to treat other cancers in ongoing clinical trials –&nbsp;is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.</p>

    Placeholder image
  • Men's and Women's Immune Systems Respond Differently to PTSD

    Men and women had starkly different immune system responses to chronic post-traumatic stress disorder, with men showing no response and women showing a strong response, in two studies by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.

    Placeholder image
  • UCSF Study Revisits First Clinical Trial to Treat Multiple Sclerosis Decades Later

    <p><span class="Apple-style-span">More than two decades after a pivotal clinical trial of a drug was used to treat multiple sclerosis, researchers are reporting a surprising discovery:&nbsp;the people who received interferon in the trial, as opposed to a placebo, were only about half as likely to have died in years since.</span></p>

    Placeholder image
  • UCSF Team Shows How to Make Skinny Worms Fat and Fat Worms Skinny

    Researchers exploring human metabolism at UCSF have uncovered a handful of chemical compounds that regulate fat storage in worms, offering a new tool for understanding obesity and finding future treatments for diseases associated with obesity.

    Placeholder image